Effectiveness of homoeopathic medicines in the management of Lumbar Spondylosis

Phase 2

Not yet recruiting

• Conditions: Spondylosis,

• Registration Number: CTRI/2023/07/055470
• Lead Sponsor: NATIONAL INSTITUTE OF HOMOEOPATHY

Brief Summary

Lumbar spondylosis is a degenerative disorder of the lumbar spine characterized clinically by an insidious onset of pain and stiffness and radiologically by osteophyte formation. This is one of the commonest cause of backache. Incidence of lumbar spondylosis is more in the age group 30- 50 years. According to 2022 ICD-10-CM codes the diagnostic code M47.816 is used for spondylosis, without myelopathy or radiculopathy, lumbar region. Oswestry low back pain disability questionnaire score is one of the principal condition specific outcome measures used in the management of spinal disorders. Kent’s Repertory contains a lot of rubrics related to lumbar spondylosis. Conducting a prospective clinical study using general Repertory like Kent’s Repertory will help in verifying the homoeopathic principles and enriching the study of our Materia Medica.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2023-07-20
• Study Start: 2023-07-31

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

• Subjects of age group 30 years to 70 years.
• Patients presenting with clinical features and radiological findings of lumbar spondylosis.
• Patients of all genders.
• Patients willing to give informed consent to participate in the study.

Exclusion Criteria

• Cases with congenital lumbar anomalies ( eg, Sacralization of fifth lumbar vertebrae, Spina bifida etc) 2.
• Patients unwilling to give consent for taking part in the study and regular follow ups.
• Pregnant and lactating women.
• Persons with terminal or life threatening illness.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Oswestry Low Back Pain Disability Questionnaire	At baseline & at the end of 6th month

Secondary Outcome Measures

Name	Time	Method
Not applicable	Not applicable

Trial Locations

Locations (1)

National Institute of Homoeopathy, Kolkata; 🇮🇳 Parganas, WEST BENGAL, India

National Institute of Homoeopathy, Kolkata

🇮🇳Parganas, WEST BENGAL, India

Dr G R Divya Jyoti Anand

Principal investigator

8584014456

djyoti02@gmail.com